NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%

  • Oppenheimer cut the price target on NVIDIA Corporation NVDA from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to $158.86 in pre-market trading.
  • Raymond James cut the price target for Jounce Therapeutics, Inc. JNCE from $16 to $3. Raymond James analyst Steven Seedhouse downgraded the stock from Strong Buy to Outperform. Jounce Therapeutics shares fell 41.2% to close at $1.17 on Thursday.
  • Jefferies cut the price target on Outbrain Inc. OB from $6.5 to $4. Outbrain shares jumped 17.3% to close at $4.40 on Thursday.
  • Raymond James slashed the price target for NeoGenomics, Inc. NEO from $15 to $12. NeoGenomics shares rose 2.6% to $10.34 in pre-market trading.
  • Keybanc slashed the price target for STERIS plc STE from $240 to $210. STERIS shares gained 5.2% to close at $169.27 on Thursday.
  • Piper Sandler boosted the price target on Wix.com Ltd. WIX from $78 to $80. Wix.com shares gained 0.4% to $84.00 in pre-market trading.
  • SVB Leerink cut the price target on Landos Biopharma, Inc. LABP from $3 to $2. Landos Biopharma shares jumped 17.4% to close at $0.27 on Thursday.

Check out this: $10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying

Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookAnalyst RatingsTrading IdeasPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!